post-epidemic eosinophilia myalgia syndrome l-tryptophan abstract eosinophilia myalgia syndrome ems characterized subacute onset myalgias peripheral eosinophilia chronic neuropathy skin induration epidemic ems num linked l-tryptophan consumption originating single source food drug administration fda ban sale l-tryptophan incidence ems declined rapidly cases published fda ban lifted num report clinical histopathological immunogenetic features case l-tryptophan-associated ems evidence activated transforming growth factor interleukin num signaling lesional skin 
